Informed consent is a fundamental ethical and legal requirement in clinical research, ensuring that participants voluntarily agree to take part in a trial after being fully informed of all relevant aspects. Under ICH E6, the informed consent process must protect the rights, safety, and well-being of human subjects.
What Is the Informed Consent Process?
The informed consent process involves providing potential trial subjects with comprehensive information about the study’s purpose, duration, procedures, risks, benefits, and alternatives. The process must be conducted in a setting that minimizes undue influence or coercion, and subjects must be given sufficient time to consider their participation. Consent must be obtained before any trial-related procedures are performed, and the subject’s capacity to provide consent must be assessed by the investigator.
Regulatory Framework
Regulatory requirements for informed consent are detailed in 21 CFR Part 50 in the United States, the Declaration of Helsinki, and ICH E6 Section 4.8. These regulations specify the eight essential elements that must be included in every informed consent form, such as the investigational nature of the trial, foreseeable risks and discomforts, and the voluntary nature of participation with the right to withdraw at any time without penalty.
Key Requirements
The informed consent document must be approved by the Institutional Review Board (IRB) or Ethics Committee before use, and any subsequent amendments require reapproval. The person obtaining consent must be the investigator or a qualified designee who is thoroughly knowledgeable about the trial. Each consent form must be signed and dated by the subject or a legally authorized representative, and the subject must receive a copy of the signed document.
Documentation
The signed informed consent form is an essential document that must be retained in the Trial Master File (TMF) and the subject’s medical records. The investigator must also document in the source records the date and time consent was obtained, the identity of the person who conducted the consent discussion, and any reconsent activities if new safety information emerges during the trial. Inspection of consent documentation is a standard part of regulatory audits.
Conclusion
The informed consent process is a cornerstone of ethical clinical research that respects participant autonomy. Strict adherence to regulatory requirements regarding content, timing, and documentation is essential. Investigators must ensure that consent is truly informed and voluntary at every stage of the clinical trial.
